Beyond Spirometry : Linking Wasted Ventilation to Exertional Dyspnea in the Initial Stages of COPD
Exertional dyspnea, a key complaint of patients with chronic obstructive pulmonary disease (COPD), ultimately reflects an increased inspiratory neural drive to breathe. In non-hypoxemic patients with largely preserved lung mechanics - as those in the initial stages of the disease - the heightened inspiratory neural drive is strongly associated with an exaggerated ventilatory response to metabolic demand. Several lines of evidence indicate that the so-called excess ventilation (high ventilation-CO2 output relationship) primarily reflects poor gas exchange efficiency, namely increased physiological dead space. Pulmonary function tests estimating the extension of the wasted ventilation and selected cardiopulmonary exercise testing variables can, therefore, shed unique light on the genesis of patients' out-of-proportion dyspnea. After a succinct overview of the basis of gas exchange efficiency in health and inefficiency in COPD, we discuss how wasted ventilation translates into exertional dyspnea in individual patients. We then outline what is currently known about the structural basis of wasted ventilation in "minor/trivial" COPD vis-à-vis the contribution of emphysema versus a potential impairment in lung perfusion across non-emphysematous lung. After summarizing some unanswered questions on the field, we propose that functional imaging be amalgamated with pulmonary function tests beyond spirometry to improve our understanding of this deeply neglected cause of exertional dyspnea. Advances in the field will depend on our ability to develop robust platforms for deeply phenotyping (structurally and functionally), the dyspneic patients showing unordinary high wasted ventilation despite relatively preserved FEV1.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
COPD - 21(2024), 1 vom: 29. Feb., Seite 2301549 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Neder, J Alberto [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Blood flow |
|---|
| Anmerkungen: |
Date Completed 14.02.2024 Date Revised 14.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/15412555.2023.2301549 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368389707 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368389707 | ||
| 003 | DE-627 | ||
| 005 | 20240214233420.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240213s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/15412555.2023.2301549 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1293.xml |
| 035 | |a (DE-627)NLM368389707 | ||
| 035 | |a (NLM)38348843 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Neder, J Alberto |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Beyond Spirometry |b Linking Wasted Ventilation to Exertional Dyspnea in the Initial Stages of COPD |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.02.2024 | ||
| 500 | |a Date Revised 14.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Exertional dyspnea, a key complaint of patients with chronic obstructive pulmonary disease (COPD), ultimately reflects an increased inspiratory neural drive to breathe. In non-hypoxemic patients with largely preserved lung mechanics - as those in the initial stages of the disease - the heightened inspiratory neural drive is strongly associated with an exaggerated ventilatory response to metabolic demand. Several lines of evidence indicate that the so-called excess ventilation (high ventilation-CO2 output relationship) primarily reflects poor gas exchange efficiency, namely increased physiological dead space. Pulmonary function tests estimating the extension of the wasted ventilation and selected cardiopulmonary exercise testing variables can, therefore, shed unique light on the genesis of patients' out-of-proportion dyspnea. After a succinct overview of the basis of gas exchange efficiency in health and inefficiency in COPD, we discuss how wasted ventilation translates into exertional dyspnea in individual patients. We then outline what is currently known about the structural basis of wasted ventilation in "minor/trivial" COPD vis-à-vis the contribution of emphysema versus a potential impairment in lung perfusion across non-emphysematous lung. After summarizing some unanswered questions on the field, we propose that functional imaging be amalgamated with pulmonary function tests beyond spirometry to improve our understanding of this deeply neglected cause of exertional dyspnea. Advances in the field will depend on our ability to develop robust platforms for deeply phenotyping (structurally and functionally), the dyspneic patients showing unordinary high wasted ventilation despite relatively preserved FEV1 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Dsypnea | |
| 650 | 4 | |a blood flow | |
| 650 | 4 | |a emphysema | |
| 650 | 4 | |a gas exchange | |
| 650 | 4 | |a mild COPD | |
| 700 | 1 | |a Santyr, Giles |e verfasserin |4 aut | |
| 700 | 1 | |a Zanette, Brandon |e verfasserin |4 aut | |
| 700 | 1 | |a Kirby, Miranda |e verfasserin |4 aut | |
| 700 | 1 | |a Pourafkari, Marina |e verfasserin |4 aut | |
| 700 | 1 | |a James, Matthew D |e verfasserin |4 aut | |
| 700 | 1 | |a Vincent, Sandra G |e verfasserin |4 aut | |
| 700 | 1 | |a Ferguson, Carrie |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Chu-Yi |e verfasserin |4 aut | |
| 700 | 1 | |a Domnik, Nicolle J |e verfasserin |4 aut | |
| 700 | 1 | |a Phillips, Devin B |e verfasserin |4 aut | |
| 700 | 1 | |a Porszasz, Janos |e verfasserin |4 aut | |
| 700 | 1 | |a Stringer, William W |e verfasserin |4 aut | |
| 700 | 1 | |a O'Donnell, Denis E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t COPD |d 2004 |g 21(2024), 1 vom: 29. Feb., Seite 2301549 |w (DE-627)NLM165577150 |x 1541-2563 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2024 |g number:1 |g day:29 |g month:02 |g pages:2301549 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/15412555.2023.2301549 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2024 |e 1 |b 29 |c 02 |h 2301549 | ||